carboplatin and paclitaxel
Sponsors
Eisai Inc., Rigshospitalet, Denmark, The Netherlands Cancer Institute, Danish Gynecological Cancer Group, Korean Gynecologic Oncology Group
Conditions
Breast CancerEndometrial CancerFallopian TubeFallopian Tube CancerHigh Grade Serous OvarianLocally Advanced Head and Neck Squamous Cell CarcinomaNon-small Cell Lung CancerOvarian Cancer
Phase 1
Phase 2
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
Active, not recruitingNCT01057069
Start: 2010-01-31End: 2029-12-31Updated: 2022-10-12
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Active, not recruitingNCT01244789
Start: 2011-12-31End: 2028-07-01Updated: 2025-07-23
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01570582
Start: 2010-03-31End: 2014-03-31Target: 314Updated: 2012-04-04
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
NCT03935256
Start: 2019-03-05End: 2024-12-31Target: 24Updated: 2023-12-18
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
TerminatedNCT04527900
Start: 2021-02-23End: 2024-07-02Updated: 2025-06-19
Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
WithdrawnNCT05743270
Start: 2024-01-30End: 2026-06-01Updated: 2025-03-11
Phase 3
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
CompletedNCT00050960
Start: 2002-05-31End: 2005-03-31Updated: 2012-07-13
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
TerminatedNCT00273507
Start: 1998-01-31End: 2006-01-31Target: 270Updated: 2009-09-18